Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme
Clinical trial NCT01209442 · COMPLETED
Trial details
- NCT number
- NCT01209442
- Sponsor
- University of Colorado, Denver
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-16
- Primary completion
- 2014-09-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.